Further characterization of CD45+CD3+CD8+ cells in the DLN of tumor bearing mice showed that in PBS-treated EMT6siCD200 tumor bearing hosts, CD8+ cells expressed more IFNγ than the corresponding cells from control EMT6 tumor bearing hosts (Fig 4E-left hand bars). This evidence concerns the gene PTPRC and neoplasm.